Compliance Rate

Compliance Rate 0%
Compliant submissions 0
Incompliant submissions 0
Total trials 0

My Organizations' Clinical Trials

Showing 425 of 1631 entries
View as:

Placebo Controlled, Randomized, Double-blind, Multi-center Study to Investigate the Efficacy and Tolerability of BAY58-2667

Phase: N/A Priority: Normal
NCT ID: NCT00559650 Org: User:
Start: 12/31/07 End: 03/31/09 Due: 03/31/10

A Trial to Learn What Happens to Different Medicinal Forms of BAY2328065 When They Enter the Body and How Safe They Are in Healthy Male and Female Participants

Phase: N/A Priority: Normal
NCT ID: NCT04851483 Org: User:
Start: 04/28/21 End: 02/14/22 Due: 02/14/23

Metabolism Study to Investigate the Impact of a Sequential Oral Contraceptive

Phase: N/A Priority: Normal
NCT ID: NCT00185224 Org: User:
Start: 03/31/05 End: 03/31/06 Due: 03/31/07

Extension at 10 Years of the: "Observational Study Evaluating Efficacy and Costs of Secondary Prophylaxis vs On-demand Therapy With Kogenate Bayer in Patients With Severe Haemophilia A."

Phase: N/A Priority: Normal
NCT ID: NCT02581969 Org: User:
Start: 04/14/16 End: 06/21/18 Due: 06/21/19

Study to Compare How the Body Distributes and Excretes the Drugs Jivi (BAY 94-9027) and Adynovi in Patients With Severe Hemophilia A (Bleeding Disorder Resulting From a Lack of Blood Clotting Factor VIII)

Phase: N/A Priority: Normal
NCT ID: NCT04015492 Org: User:
Start: 08/08/19 End: 01/29/20 Due: 01/29/21

BAY59-7939 in Atrial Fibrillation Once Daily (OD)

Phase: N/A Priority: Normal
NCT ID: NCT00973245 Org: User:
Start: 07/31/06 End: 01/31/07 Due: 01/31/08

Japanese Treat and Extend Study of Aflibercept in Neovascular Age-related Macular Degeneration

Phase: N/A Priority: Normal
NCT ID: NCT02305238 Org: User:
Start: 12/19/14 End: 12/20/17 Due: 12/20/18

Open Label Study to Evaluate Effect, Safety and Tolerability of Betaferon Standard Dose of 250µg in Patients of Chinese Origin With Multiple Sclerosis

Phase: N/A Priority: Normal
NCT ID: NCT00370071 Org: User:
Start: 11/30/06 End: 09/30/08 Due: 09/30/09

Xarelto [SPAF-QOL] Post-marketing Surveillance in Japan

Phase: N/A Priority: Normal
NCT ID: NCT01598051 Org: User:
Start: 05/31/12 End: 03/31/17 Due: 03/31/18

A Study Using Available Data to Learn to What Extent Patients With Prostate Cancer Who Received Second Generation Androgen Receptor Inhibitors Took Their Medication as Prescribed or Stopped Taking Their Medication Completely

Phase: N/A Priority: Normal
NCT ID: NCT05202301 Org: User:
Start: 01/15/22 End: 07/15/25 Due: 07/15/26

Electronic Activity Level Monitoring Pilot in Pulmonary Hypertension

Phase: N/A Priority: Normal
NCT ID: NCT02536534 Org: User:
Start: 06/30/15 End: 12/21/16 Due: 12/21/17

Efficacy/Safety Study to Explore a New Topical Formulation in Atopic Dermatitis

Phase: N/A Priority: Normal
NCT ID: NCT01691209 Org: User:
Start: 10/31/13 End: 06/30/14 Due: 06/30/15

Betaseron 16-Year Long-Term Follow-Up (LTF) in Patients With Relapsing-Remitting Multiple Sclerosis

Phase: N/A Priority: Normal
NCT ID: NCT00206635 Org: User:
Start: 01/31/05 End: 12/31/05 Due: 12/31/06

Extension Study to Evaluate the Long-term Outcomes of Subjects in Study 20090

Phase: N/A Priority: Normal
NCT ID: NCT04015180 Org: User:
Start: 03/18/20 End: 10/01/25 Due: 10/01/26

A Clinical Study on Yasmin® vs. Marvelon® in Chinese Women Requiring Contraception

Phase: N/A Priority: Normal
NCT ID: NCT00185419 Org: User:
Start: 11/30/03 End: 03/31/06 Due: 03/31/07

Evaluation of the Neuroinflammation Pattern of BAY85-8102 F-18, DPA-714 in Probable Alzheimers Disease Patients Versus Healthy Volunteers and Radiation Dosimetry of F 18, DPA-714 in Healthy Volunteers

Phase: N/A Priority: Normal
NCT ID: NCT01009359 Org: User:
Start: 10/31/09 End: 10/31/10 Due: 10/31/11

Study of the Effects of High Dose Aflibercept Injected Into the Eye of Patients With an Age-related Disorder That Causes Loss of Vision Due to Growth of Abnormal Blood Vessels at the Back of the Eye

Phase: N/A Priority: Normal
NCT ID: NCT04423718 Org: User:
Start: 08/11/20 End: 08/07/24 Due: 08/07/25

Relative Bioavailability and Food Effect Study

Phase: N/A Priority: Normal
NCT ID: NCT01489488 Org: User:
Start: 01/31/12 End: 05/31/12 Due: 05/31/13

Riociguat rEplacing PDE-5i Therapy evaLuated Against Continued PDE-5i thErapy

Phase: N/A Priority: Normal
NCT ID: NCT02891850 Org: User:
Start: 01/11/17 End: 03/03/20 Due: 03/03/21

Determination of Sun Protection in Sunscreen Formulas (Study SR09-15)(P08236)(COMPLETED)

Phase: N/A Priority: Normal
NCT ID: NCT01001975 Org: User:
Start: 07/31/09 End: 08/31/09 Due: 08/31/10

BAYQ3939, 1000 mg Tablet in Transrectal Needle Biopsies of the Prostate (TRNBP) - Infection Prophylaxis

Phase: N/A Priority: Normal
NCT ID: NCT00670215 Org: User:
Start: 04/30/04 End: 10/31/04 Due: 10/31/05

Sun Protection Factor Assay (SPF Assay 206/2016)

Phase: N/A Priority: Normal
NCT ID: NCT02936570 Org: User:
Start: 10/26/16 End: 11/01/16 Due: 11/01/17

Phase 1 Study of the Combination of Rogaratinib With Copanlisib in Patients With Fibroblast Growth Factor Receptor (FGFR)-Positive, Locally Advanced or Metastatic Solid Tumors

Phase: N/A Priority: Normal
NCT ID: NCT03517956 Org: User:
Start: 07/25/18 End: 02/01/21 Due: 02/01/22

BAY63-2521 - Long-term Extension Study in Patients With Chronic Thromboembolic Pulmonary Hypertension

Phase: N/A Priority: Normal
NCT ID: NCT00910429 Org: User:
Start: 07/01/09 End: 08/19/19 Due: 08/19/20

Trial to Evaluate Time to Symptom Relief and Elimination of Infecting Bacteria in Treating Sinusitis With Avelox

Phase: N/A Priority: Normal
NCT ID: NCT00668304 Org: User:
Start: 06/30/04 End: 01/31/05 Due: 01/31/06